P2X7 Receptor: an Emerging Target in Alzheimer's Disease

Mol Neurobiol. 2024 May;61(5):2866-2880. doi: 10.1007/s12035-023-03699-9. Epub 2023 Nov 9.

Abstract

Alzheimer's disease (AD) is a major cause of age-related dementia, which is becoming a global health crisis. However, the pathogenesis and etiology of AD are still not fully understood. And there are no valid treatment methods or precise diagnostic tools for AD. There is increasing evidence that P2X7R expression is upregulated in AD and is involved in multiple related pathological processes such as Aβ plaques, neurogenic fiber tangles, oxidative stress, and chronic neuroinflammation. This suggests that P2X7R may be a key player in the development of AD. P2X7R is a member of the ligand-gated purinergic receptor (P2X) family. It has received attention in neuroscience due to its role in a wide range of aging and age-related neurological disorders. In this review, we summarize current information on the roles of P2X7R in AD and suggest potential pharmacological interventions to slow down AD progression.

Keywords: Alzheimer’s disease; Mitochondrial dysfunction; Neuroinflammation; Oxidative stress; P2X7R.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease* / metabolism
  • Alzheimer Disease* / pathology
  • Animals
  • Humans
  • Molecular Targeted Therapy
  • Oxidative Stress / physiology
  • Purinergic P2X Receptor Antagonists / pharmacology
  • Purinergic P2X Receptor Antagonists / therapeutic use
  • Receptors, Purinergic P2X7* / metabolism

Substances

  • Receptors, Purinergic P2X7
  • Purinergic P2X Receptor Antagonists